Prelude Therapeutics is a biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 51-200
Address: 200 Powder Mill Road
City: Wilmington
State: DE
Zip: 19803
Country: US
Prelude Therapeutics is a biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of cancer.
Contact Phone:
+13024671280
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/24/2020
IPO Valuation:
$807M
Ticker Symbol:
PRLD
IPO Price:
$19/share
Amount Raised:
$158M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2017 | Venture Round | $12M | 6/2019 | Series B | 1 | $60M |
OrbiMed OrbiMed OrbiMed OrbiMed |
5/2019 | Series B | $60M |
OrbiMed Advisors LLC |
10/2017 | Equity | $30M | 6/2016 | Equity | $5M | 8/2020 | Series C | 2 | $50M |
OrbiMed Fidelity Management and Research Company Fidelity Management and Research Company OrbiMed OrbiMed Fidelity Management and Research Company Fidelity Management and Research Company OrbiMed |
9/2020 | IPO | $100M |
|
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|